CUSIP: 66737P600
Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
669,855
-
Share change
-
+62,775
-
Total reported value
-
$286,210
-
Price per share
-
$0.43
-
Number of holders
-
11
-
Value change
-
+$26,792
-
Number of buys
-
3
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 66737P600?
CUSIP 66737P600 identifies NWBO - NORTHWEST BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2024
-
Previous quarter:
Q1 2024
Recent filing periods for CUSIP 66737P600:
Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) as of Q2 2024
As of 30 Jun 2024,
NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
669,855 shares.
The largest 10 holders included
Moloney Securities Asset Management, LLC, Opus Capital Group, LLC, MARIPAU WEALTH MANAGEMENT LLC, Williams Jones Wealth Management, LLC., Ethos Financial Group, LLC, LEE DANNER & BASS INC, MAI Capital Management, AlphaMark Advisors, LLC, Sentinus, LLC, and ADVISORS MANAGEMENT GROUP INC /ADV.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.